aclacinomycin has been researched along with Pleural Effusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Homma, T; Min, KY; Nakagawa, H; Yoneda, S; Yoshida, S | 1 |
| Fujii, M; Fujita, Y; Ishimitsu, T; Okabe, K; Toki, H | 1 |
2 other study(ies) available for aclacinomycin and Pleural Effusion
| Article | Year |
|---|---|
[Aclacinomycin; benefits for the treatment of malignant pleural effusion].
Topics: Aclarubicin; Adenocarcinoma; Aged; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Naphthacenes; Pleural Effusion; Rabbits | 1983 |
[Efficacy of intrapleural treatment with aclacinomycin combined with closed tube thoracostomy for malignant pleural effusion].
Topics: Aclarubicin; Adenocarcinoma; Adult; Aged; Drainage; Female; Humans; Intubation; Lung Neoplasms; Male; Middle Aged; Naphthacenes; Pleural Effusion; Thorax | 1984 |